We then observed that combined HA-PEI/HA-PEG/MDR1 siRNA CD44 targeted nanoparticle and paclitaxel treatment decreased Pgp expression and increased apoptosis in MDR cells in tumor tissues from tumor-bearing mice. Here, CD44 is linked to neoplasm.